Efficacy and Safety of Ingenol Mebutate in Patients With Actinic Keratosis on Face and Scalp: Subgroup Analysis of Two Vehicle-Controlled Trials According to Age (<65 and ≥65 Years)

Main Article Content

Hee Kim
Jes Hansen
Mads Faurby
et al.

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Leo Pharma.